twitter
en POLSKI
eISSN: 2719-3209
ISSN: 0023-2157
Klinika Oczna / Acta Ophthalmologica Polonica
Current issue Archive Videos Articles in press About the journal Supplements Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
2/2005
vol. 107
 
Share:
Share:
abstract:
Review paper

Therapy of wet form of age-related macular disease: the present state and perspectives

Małgorzata Figurska
1
,
Andrzej Stankiewicz
1

  1. Klinika Okulistyki Wojskowego Instytutu Medycznego w Warszawie
Klinika Oczna 2005, 107(4-6): 334-339
Online publish date: 2005/07/02
View full text Get citation
 
Age-related macular disease (ARMD) is affecting the central part of the retina. ARMD has two major forms: the dry type and the wet type. Although wet type comprises only 15% of ARMD, it is responsible for 90% of severe visual impairment in all ARMD cases. The problem is effective treatment of ARMD, above all its wet type. Laser therapy, retina surgery, TTT and local radiotherapy did not give expected results. The aim of this article is to present modern trends of wet type ARMD therapy, including pharmacotherapy and photodynamic therapy (PDT) in relation to pathobiology of choroidal neovascularization (CNV). The goals of pharmacotherapy were discussed in support, that choroidal neovascularization is a dynamic evolution, which includes initiation, active inflammation and non active involution. Cellular mechanisms of photodynamic therapy were presented. It is necessary to accentuate that in the future it can be a combination between PDT and pharmacotherapy, which inhibits early stage mediators of all types CNV and limits inflammation attendant CNV. These therapeutic approaches ere more likely succeed and included wide spectrum of wet ARMD pathogenesis. The clinical studies show that may be soon we will treat wet form of ARMD using angiostatic steroids, anti-VEGF monoclonal antibodies and anti-VEGF aptamers.
keywords:

wet form of age-related macular disease (ARMD), pathobiology of ARMD, inflammatory and angiogenic factors, aims of wet ARMD pharmacotherapy, photodynamic therapy, pegaptanib sodium, rhuFab V2, gen therapy, AdPEDF, Anacortave acetate, Triamcynolone acetonide, statins, angiostatins

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.